TAKE THIS POLL |
|
|
- State data: Melanoma higher than expected in whitest, wealthiest towns 7 Sep 2008 01:19 GMT
... technology, was double the number expected in Sharon and Hanson, while esophagus cancer and multiple myeloma were especially high in Stoughton. Of all South Shore towns, Plymouth most exceeded the ...
- Elan And Biogen Idec Initiate First Clinical Trial Of TYSABRI(R) In Oncology - First Multiple Myeloma Patient Treated 6 Sep 2008 21:27 GMT
... the safety and potential anti-tumor activity of TYSABRI in patients with relapsed or refractory multiple myeloma. TYSABRI is a recombinant, humanized monoclonal antibody that targets the adhesion molecule VLA4 (also ...
- Tysabri testing underway 6 Sep 2008 20:33 GMT
... clinical trial to test whether Tysabri can be used to treat relapsed or refractory multiple myeloma, a type of cancer of plasma cells. And in the long run, the companies ...
- Melanoma higher than expected in whitest, wealthiest Shore Shore towns 6 Sep 2008 17:58 GMT
... technology, was double the number expected in Sharon and Hanson, while esophagus cancer and multiple myeloma were especially high in Stoughton. Of all South Shore towns, Plymouth most exceeded the ...
- New FDA list identifies drugs with safety issues 6 Sep 2008 15:32 GMT
... thinner, drug interaction. Tykerb , for advanced breast cancer, liver damage. Revlimid , for multiple myeloma, severe skin blisters and bleeding. Tysabri , for multiple sclerosis, skin melanomas. Nitrostat , ...
- FDA to begin posting list of drugs under investigation 6 Sep 2008 14:37 GMT
... a blood thinner; drug interaction Tykerb: for advanced breast cancer; liver damage Revlimid: for multiple myeloma; severe skin blistering and bleeding Nitrostat: for angina; overdose due to labeling confusion Sandostatin ...
- FDA to regularly post list of drugs whose safety is under investigation 6 Sep 2008 13:34 GMT
... to labeling confusion. Oxycontin, a pain killer; drug misuse, abuse and overdose. Revlimid, for multiple myeloma; severe skin blistering and bleeding. R-Gene 10, a growth hormone; pediatric overdose due to ...
- FDA to update public on drug investigations 6 Sep 2008 13:27 GMT
... interaction. • Tykerb , for advanced breast cancer, liver damage. • Revlimid , for multiple myeloma, severe skin blistering and bleeding. • Tysabri , for multiple sclerosis, skin melanomas. • ...
- Elan seeks second-round bids for €1bn EDT drug unit 6 Sep 2008 12:28 GMT
... have have launched the first clinical trial Tysabri for patients with relapsed or refractory multiple myeloma, they said yesterday. The first dose was administered on Thursday. Multiple myeloma is a ...
- FDA releases first list of drugs that might have safety issues 6 Sep 2008 10:59 GMT
... a blood thinner, drug interaction. Tykerb, for advanced breast cancer, liver damage. Revlimid, for multiple myeloma, severe skin blistering and bleeding. Nitrostat, for angina, overdose caused by labeling confusion. Sandostatin ...
- Remembering a pioneer: Dr. Charles Whitten 6 Sep 2008 06:34 GMT
... cell disease specialist is scheduled for 2 p.m. Saturday. Whitten died from complications of multiple myeloma on Aug. 14 at his Detroit home. He was 86. His memorial will be ...
- Tysabri Trial for Multiple Myeloma Gets Under Way 6 Sep 2008 03:36 GMT
... > Tysabri Trial for Multiple Myeloma Gets Under Way Sept. 8, 2008 | Vol. 7 No. 175 Tysabri Trial for ...
- Local campaigners cheer network joint... 6 Sep 2008 02:56 GMT
... dedicate his efforts to fighting lymphoma. he's also taken part in events focusing on multiple myeloma, which claimed his father-in-law's life, and for breast cancer, which struck his wife several ...
- FDA Posts Quarterly List Of Questionable Drugs 6 Sep 2008 02:51 GMT
... retention. Also on the list, Tysabri for reports of melanoma skin cancer. Revlimid, for multiple myeloma has been linked to a skin condition that is potentially life-threatening. The lists will ...
- FDA posts list of prescription drugs with possible problems 5 Sep 2008 22:59 GMT
... a blood thinner, drug interaction. Tykerb, for advanced breast cancer, liver damage. Revlimid, for multiple myeloma, severe skin blistering and bleeding. Nitrostat, for angina, overdose due to labeling confusion. Sandostatin ...
- List of medications under investigation for potential safety issues 5 Sep 2008 22:08 GMT
... a blood thinner, drug interaction. _Tykerb, for advanced breast cancer, liver damage. _Revlimid, for multiple myeloma, severe skin blistering and bleeding. _Tysabri, for multiple sclerosis, skin melanomas. _Nitrostat, for angina, ...
- FDA posts list of potential problem drugs 5 Sep 2008 21:30 GMT
... a blood thinner, drug interaction. -Tykerb, for advanced breast cancer, liver damage. -Revlimid, for multiple myeloma, severe skin blistering and bleeding. -Tysabri, for multiple sclerosis, skin melanomas. -Nitrostat, for angina, ...
- Biogen to test Tysabri as a cancer treatment 5 Sep 2008 21:05 GMT
... announced on Friday that they have launched a clinical trial using Tysabri to combat multiple myeloma, or a cancer that affects plasma cells in the blood. As many as 30 ...
- List of medications with potential safety problems 5 Sep 2008 21:04 GMT
... a blood thinner, drug interaction. -Tykerb, for advanced breast cancer, liver damage. -Revlimid, for multiple myeloma, severe skin blistering and bleeding. -Nitrostat, for angina, overdose due to labeling confusion. -Sandostatin ...
- Biogen Idec's Tysabri to be tested as cancer treatment 5 Sep 2008 20:48 GMT
... ELN) announced on Friday that they launched a clinical trial using Tysabri to combat multiple myeloma. Up to 30 patients will be involved in the trial for at least six ...
- Banks drag ISEQ shares 3.6pc lower 5 Sep 2008 20:32 GMT
... the first patient has been dosed in a Phase I/II trial of Tysabri in multiple myeloma (cancer of the plasma cell). In the Phase I portion of this trial, up ...
- Massachusetts opens Beijing trade office 5 Sep 2008 19:55 GMT
... ELN) announced on Friday that they launched a clinical trial using Tysabri to combat multiple myeloma. Up to 30 patients will be involved in the trial for at least six ...
- Massachusetts opens Beijing trade office 5 Sep 2008 19:51 GMT
... ELN) announced on Friday that they launched a clinical trial using Tysabri to combat multiple myeloma. Up to 30 patients will be involved in the trial for at least six ...
- Elan and Biogen Idec Initiate First Clinical Trial of Tysabri in Oncology 5 Sep 2008 16:37 GMT
... Wayne Saville, MD, Director, Oncology Medical Research at Biogen Idec. "TYSABRI has potential in multiple myeloma and a number of other cancers through its action as a blocker of VLA4. ...
- Biogen and Elan start testing Tysabri in cancer 5 Sep 2008 16:34 GMT
... goal is to determine the safety and effectiveness of Tysabri in patients who have multiple myeloma, a cancer of bone marrow plasma cells. The patients have either have not responded ...
1 - 25 of 251 next >
News by PR Newswire
|
